voacamine has been researched along with cyclosporine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arancia, G; Calcabrini, A; Federici, E; Galeffi, C; Marra, M; Meschini, S | 1 |
| Arancia, G; Calcabrini, A; Cianfriglia, M; Condello, M; Dupuis, ML; Federici, E; Marra, M; Meschini, S | 1 |
2 other study(ies) available for voacamine and cyclosporine
| Article | Year |
|---|---|
Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells.
Topics: Alkaloids; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gentiana; Humans; Ibogaine; Microscopy, Confocal; Microscopy, Electron, Scanning; Plant Extracts | 2003 |
Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
Topics: Alkaloids; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Ibogaine; Microscopy, Confocal; Microscopy, Electron, Scanning; Osteosarcoma; Plant Bark; Plant Extracts | 2005 |